ImageneBio Inc
ImageneBio Inc (IMA) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · IMA · as of Sep 30, 2025
Ownership Breakdown
32
Institutional Holders
▲ 32 vs Q2
$38.35M
Total Inst. Value
▲ $38.35M vs Q2
11.28M
Shares Outstanding
freeFloat 64.40%
4.71M
13F Shares Held
▲ 4.71M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
IMA largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
DEEP TRACK CAPITAL, LP biological products, (no diagnostic substances) | 878.5K | 10.30% | 10.30% | $7.16B | Nov 14, 2025 | NEW |
BVF INC/IL biological products, (no diagnostic substances) | 802.1K | 9.41% | 9.41% | $6.54B | Nov 14, 2025 | NEW |
BLUE OWL CAPITAL HOLDINGS LP biological products, (no diagnostic substances) | 540.9K | 6.34% | 6.34% | $4.41B | Nov 12, 2025 | NEW |
OMEGA FUND MANAGEMENT, LLC biological products, (no diagnostic substances) | 455.4K | 5.34% | 5.34% | $3.71B | Nov 14, 2025 | NEW |
ORBIMED ADVISORS LLC biological products, (no diagnostic substances) | 378.6K | 4.44% | 4.44% | $3.09B | Nov 14, 2025 | NEW |
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC biological products, (no diagnostic substances) | 377.8K | 4.43% | 4.43% | $3.08B | Nov 13, 2025 | NEW |
RTW INVESTMENTS, LP biological products, (no diagnostic substances) | 334.4K | 3.92% | 3.92% | $2.73B | Nov 14, 2025 | NEW |
VANGUARD GROUP INC biological products, (no diagnostic substances) | 233.4K | 2.74% | 2.74% | $1.90B | Nov 7, 2025 | NEW |
BML CAPITAL MANAGEMENT, LLC biological products, (no diagnostic substances) | 182.5K | 2.14% | 2.14% | $1.49B | Nov 10, 2025 | NEW |
CITADEL ADVISORS LLC biological products, (no diagnostic substances) | 122.2K | 1.43% | 1.43% | $996.31M | Nov 14, 2025 | NEW |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
0
Increased
+0 shares32
New Positions
first time holders0
Decreased
−0 shares0
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
+32
32 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
IMA insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
4
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Bonita David P director | Apr 14, 2026 | Purchase | 384,689 | $0.00 | $384.689 | 384.7K | Form 4 ↗ |
Bonita David P director | Apr 14, 2026 | Purchase | 336,603 | $0.00 | $336.603 | 336.6K | Form 4 ↗ |
ORBIMED ADVISORS LLC director | Apr 14, 2026 | Purchase | 384,689 | $0.00 | $384.689 | 384.7K | Form 4 ↗ |
ORBIMED ADVISORS LLC director | Apr 14, 2026 | Purchase | 336,603 | $0.00 | $336.603 | 336.6K | Form 4 ↗ |
Yarema Kristin Chief Executive Officer | Mar 16, 2026 | Award | 128,100 | $6.20 | $794.2K | 128.1K | Form 4 ↗ |
Yarema Kristin Chief Executive Officer | Mar 16, 2026 | Award | 85,400 | — | — | 85.4K | Form 4 ↗ |
Butler Erin Principal Accounting Officer | Dec 30, 2025 | Award | 22,500 | — | — | 25.6K | Form 4 ↗ |
Butler Erin Principal Accounting Officer | Dec 30, 2025 | Award | 22,500 | $7.11 | $160.0K | 22.5K | Form 4 ↗ |
SLATTERY JOSEPH P director | Dec 24, 2025 | Purchase | 16,000 | $5.99 | $95.8K | 16.0K | Form 4 ↗ |
Wang Jonathan Jian director | Dec 18, 2025 | Award | 31,200 | $6.19 | $193.1K | 31.2K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
ImageneBio Inc (IMA) is primarily owned by institutional investors, who hold approximately 41.7% of total shares outstanding. Company insiders own approximately 35.60%, while retail and public investors account for the remaining 22.68%.
The largest institutional shareholder of ImageneBio Inc is DEEP TRACK CAPITAL, LP, holding approximately 878,516 shares — equal to 10.30% of outstanding shares — as of September 30, 2025.
A total of 32 institutional investors currently hold IMA stock, with a combined institutional value of approximately $38,346,527 as of the most recent 13F filing period.
Frequently asked questions
IMA ownershipImageneBio Inc (IMA) is primarily owned by institutional investors, who hold approximately 41.7% of shares. The largest shareholder is DEEP TRACK CAPITAL, LP with a 10.30% stake. Company insiders hold 35.60%. Data sourced from SEC Form 13F as of September 30, 2025.